1. Guriev D.L, Okhapkin M.B., Karpov N.Y., Blinov D.V. The course and outcomes of preeclamptic pregnancy in relation to the type of maternal central hemodinamics // Akusherstvo i ginekologiya. (7-2). 14-19. (in Russian)
2. Titov V.N., Dmitriev V.A., Gushchina O.V. et al. Physicochemical activity of uric acid. Hyperuricosuria as an impaired biological function of endoecology and adaptation, biological reaction of excretion, inflammation and hydrodynamic arterial pressure // Uspekhi sovremennoy biologii. 2011. 131. (5). 483-502. (in Russian)
3. Bellomo G. Serum uric acid and pre-eclampsia: an update // Expert Rev. Cardiovasc. Ther. 2012. 10. 701–705.
4. Bergamini C., Cicoira M., Rossi A., Vassanelli C. Oxidative stress and hyperuricaemia:pathophysiology,clinical relevance,and therapeutic implications in chronic heart failure // Eur. J. Heart Fail. 2009. 11. (5). 444–452.
5. Bruun J.M., Helge J.W., Richelsen B., Stallknecht B. Diet and exercise reduce low-grade inflammation and macrophage infiltration in adipose tissue but not in skeletal muscle in severely obese subjects // Am. J. Physiol. Endocrinol. Metab. 2006. 290. (5). E961–E967.
6. Chambers J.C., Fusi L., Malik I.S. et al. Association of maternal endothelial disfunction with preeclampsia // J. Amer. Med. Assoc. 2001. 285. (12). 1607–1612.
7. Chang F.M., Chow S.N., Huang H.C. et al. The placental transfer and concentration difference in maternal and neonatal serum uric acid at parturition:comparison of normal pregnancies and gestosis // Biol. Res. Pregnan. Perinatol. 1987. 8. 35–39.
8. Davies K.J., Sevanian A., Muakkassah-Kelly S.F., Hochstein P. Uric acid-iron ion complexes. A new aspect of the antioxidant function of uric acid // Biochem. J. 1986. 235. (3). 747–754.
9. Duffy S.J., Biegelsen E.S., Holbrook M. et al. Iron chelation improves endothelial function in patients with coronary artery disease // Circulation. 2001. 103. 2799–2804.
10. Ghaemi-Oskouie F., Shi Y. The role of uric acid as an endogenous danger signal in immunity and inflammation // Curr. Rheumatol. Rep. 2011. 13. (2). 160–166.
11. Han H.J., Lim M.J., Lee J.H. et al. Uric acid inhibits renal proximal tubule cell proliferation via at least two signaling pathways involving PKC, MAPK, cPLA2, and NF-kB // Am. J. Physiol. Renal Physiol. 2007. 292. (1). F373–F381.
12. Johnson R.J., Feig D.I., Herrera-Acosta J., Kang D.H. Resurrection of uric acid as a causal risk factor in essential hypertension // Hypertension. 2005. 45. 18–20.
13. Li L., Frei B. Iron chelation inhibits NF-kB–mediated adhesion molecule expression by inhibiting p22 phox protein expression and NADPH oxidase activity // Arterioscler. Tromb. Vasc. Biol. 2006. 26. 2638–2643.
14. Martinon F. Detection of immune danger signals by NALP3 // J. Leukoc. Biol. 2008. 83. (3). 507–511.
15. Messerli F.H., Frochlich E.D., Dreslinski G.R. et al. Serum uric acid in essential hypertension:an indicator of renal vascular involvement // Ann. Intern. Med. 1980. 93. (6). 817–821.
16. Pennington K.A., Schlitt J.M., Jackson D.L. et al. Preeclampsia: multiple approaches for a multifactorial disease // Dis. Model. Mech. 2012. 5. (1). 9–18.
17. Yang Z., XiaohuaW., Lei J. et al. Uric acid increases fibronectin synthesis through upregulation of lysyl oxidase expression in rat renal tubular epithelial cells // Am. J. Physiol. Renal Physiol. 2010. 299. (2). F338–F346.
